Oppenheimer Asset Management Inc.

Source: SEC Form 13F · as of Mar 2026

Oppenheimer Asset Management Inc. holds 68 biotech & pharma companies tracked by BioSniper, totaling $714.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

68

Total value held

$714.0M

CompanySharesValue
JNJJOHNSON & JOHNSON610,825$149.3M
LLYELI LILLY & Co69,246$63.7M
MRKMerck & Co., Inc.492,072$59.2M
GMOptec International, Inc.565,919$42.2M
ABBVAbbVie Inc.181,363$39.4M
PMPhilip Morris International Inc202,343$33.5M
NVSNovartis AG217,125$33.2M
NVONovo Nordisk A/S836,460$30.7M
BMYBRISTOL MYERS SQUIBB CO486,825$29.5M
ZTSZoetis Inc.181,353$21.4M
UNHUnitedHealth Group Incorporated Common Stock (DE)71,421$19.3M
GILDGILEAD SCIENCES, INC.126,831$17.7M
IDXXIDEXX LABORATORIES INC /DE28,648$16.1M
MEDPMedpace Holdings Inc.27,317$13.1M
AZNASTRAZENECA PLC63,332$12.5M
GMABGenmab A/S457,508$12.3M
SNYSanofi236,508$11.4M
UTHRUNITED THERAPEUTICS Corp18,194$10.8M
ONCBeOne Medicines Ltd.32,532$9.7M
PFEPFIZER INC312,438$8.8M
VRTXVERTEX PHARMACEUTICALS INC / MA17,302$7.7M
WSTWest Pharmaceutical Services Inc.27,197$6.8M
ALNYALNYLAM PHARMACEUTICALS, INC.19,842$6.6M
BAXBaxter International Inc.301,618$5.1M
RGENREPLIGEN CORP35,128$4.1M
MCKMcKesson Corporation4,359$3.8M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.19,920$3.4M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)58,370$3.2M
CORCencora Inc.10,239$3.2M
ABTABBOTT LABORATORIES25,212$2.6M
TECHBIO-TECHNE Corp47,921$2.5M
INSMINSMED Inc14,725$2.4M
ELVElevance Health Inc.7,365$2.2M
HALOHALOZYME THERAPEUTICS, INC.29,569$1.9M
NBIXNEUROCRINE BIOSCIENCES INC14,313$1.9M
LNTHLantheus Holdings, Inc.24,505$1.9M
REGNREGENERON PHARMACEUTICALS, INC.2,405$1.9M
GMEDGlobus Medical Inc.20,414$1.8M
JAZZJazz Pharmaceuticals plc8,391$1.6M
IQVIQVIA Holdings Inc.8,164$1.4M
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)64,399$1.2M
VTRSViatris Inc85,916$1.2M
ICLRICON plc8,575$949K
IONSIONIS PHARMACEUTICALS INC11,853$890K
CRNXCrinetics Pharmaceuticals, Inc.21,730$789K
BBIOBridgeBio Pharma, Inc.10,164$755K
VCELVericel Corp22,919$737K
MDGLMADRIGAL PHARMACEUTICALS, INC.1,327$695K
ARGXARGENX SE891$651K
GRFSGrifols S.A.78,125$627K
FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)26,790$604K
IDYAIDEAYA Biosciences, Inc.15,444$515K
SUNSUNSET ISLAND GROUP7,836$509K
ABVXAbivax SA4,496$501K
ARWRARROWHEAD PHARMACEUTICALS, INC.7,740$485K
CAHCardinal Health Inc.2,224$470K
ACADACADIA PHARMACEUTICALS INC19,618$437K
BIIBBIOGEN INC.2,204$404K
MOHMolina Healthcare Inc2,046$273K
LGNDLigand Pharmaceuticals Incorporated1,284$256K
XENEXenon Pharmaceuticals Inc.4,325$251K
TERNTerns Pharmaceuticals, Inc.4,735$250K
DGXQuest Diagnostics Incorporated1,257$246K
COGTCogent Biosciences, Inc.5,610$216K
KRYSKrystal Biotech, Inc.793$205K
PGNYProgyny Inc.10,095$171K
NEOGNEOGEN CORP12,326$115K
MBOTMicrobot Medical Inc.12,454$30K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Oppenheimer Asset Management Inc. — Biotech 13F Holdings & Portfolio | BioSniper